Catalyst OrthoScience Announces Leadership Transition: Miguel A. Ramirez, MD, Appointed Chief Medical Officer

Leadership transition positions company for continued growth and evolution

Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announced the appointment of Dr. Miguel Ramirez as chief medical officer (CMO), effective immediately. Dr. Ramirez succeeds Dr. Steven Goldberg, Catalyst’s founder, who has stepped down from his roles as CMO and board member but will remain actively engaged, continuing to contribute his expertise and passion for the company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250402476648/en/

Catalyst OrthoScience has appointed Miguel A. Ramirez, MD, as chief medical officer

“It has been an incredible journey to shape Catalyst into what it is today, and I am proud of what we have accomplished together,” said Dr. Goldberg. “I am thrilled to continue contributing to our mission in a new capacity and am excited to welcome Dr. Ramirez. His leadership and expertise will make a significant impact as Catalyst continues to grow.”

Dr. Ramirez is a board-certified orthopedic surgeon who completed his fellowship in shoulder and elbow surgery at MedStar Union Memorial Hospital and is a graduate of Harvard Medical School. He has held key leadership roles, including Chairman of the Department of Orthopedic Surgery at OSF St. Francis Medical Center and Assistant Clinical Professor at the University of Illinois College of Medicine. Throughout his career, Dr. Ramirez has contributed extensively to clinical research on shoulder biomechanics and implant design, collaborated with leading orthopedic companies to develop innovative implants and surgical techniques, and been a principal investigator in multiple clinical trials, evaluating the efficacy and safety of emerging orthopedic technologies.

“We are excited to continue working with Dr. Goldberg and privileged to have Dr. Ramirez join the team as we drive the next phase of growth,” said Carl O’Connell, President and Chief Executive Officer of Catalyst OrthoScience. “We have ambitious goals, and Dr. Ramirez’s experience in clinical innovation, ASCs, and healthcare system navigation will be invaluable as we redefine shoulder arthroplasty for surgeons, healthcare facilities, payors, and patients.”

“Catalyst has already made tremendous advancements in orthopedics – I experience it in my practice and with my patients every day,” said Dr. Ramirez. “I am excited to build upon the remarkable foundation established by Dr. Goldberg and the team. With the growing demand for efficient healthcare solutions, increased ASC adoption, and Catalyst’s market positioning, I’m confident that we have the right elements in place for significant impact.”

About Catalyst OrthoScience Inc.

Naples, Florida-based Catalyst OrthoScience was founded in 2014 by orthopedic surgeon Steven Goldberg, MD, who recognized the need for less invasive shoulder replacements with fewer complications and a more natural-feeling shoulder after surgery. Catalyst is disrupting the traditional approach to shoulder replacement surgery, combining fundamental principles with forward-thinking technology to enhance precision, accuracy, and bone preservation.

Catalyst has a growing portfolio of patents and proprietary innovations designed to optimize surgeon experience and patient outcomes. The company’s total shoulder systems are available across the U.S. For more information about Catalyst, please visit www.catalystortho.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250402476648/en/

"Dr. Ramirez’s experience in clinical innovation, ASCs, and healthcare system navigation will be invaluable as we redefine shoulder arthroplasty for surgeons, healthcare facilities, payors, and patients." - Carl O'Connell, CEO of Catalyst OrthoScience.